✦ LIBER ✦

Divascan(r) in Migraine Prophylaxis. Open Trial with Three Different Doses

✍ Scribed by P.O. Osterman

Book ID: 115312179
Publisher: John Wiley and Sons
Year: 1978
Tongue: English
Weight: 31 KB
Volume: 18
Category: Article
ISSN: 0017-8748
DOI: 10.1111/j.1526-4610.1978.hed1804225.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of cinnarizine in th

Efficacy and safety of cinnarizine in the prophylaxis of migraine headaches in children: an open, randomized comparative trial with propranolol

✍ Mansoureh Togha; Reza Azizi Malamiri; Neda Rashidi-Ranjbar; Solmaz Asa; Farhad M 📂 Article 📅 2012 🏛 Royal Association of Belgian Medical Scientific So 🌐 English ⚖ 179 KB

Efficacy and tolerability of three diffe

Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial

✍ K. Wolff; C. Fleming; J. Hanifin; K. Papp; S. Reitamo; M. Rustin; N. Shear; W. S 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

Pharmacokinetics and tolerability of sin

Pharmacokinetics and tolerability of single escalating doses of fampridine sustained-release tablets in patients with multiple sclerosis: A phase I–II, open-label trial

✍ Timothy Vollmer; Herbert R. Henney III 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 224 KB

A multi-centre randomized trial of two d

A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset Type 1 diabetes (the IMDIAB VI)

✍ Natalia Visalli; Maria G. Cavallo; Alberto Signore; Marco G. Baroni; Raffaella B 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

Background Intensive insulin therapy is the gold standard by which Type 1 diabetes is treated. In addition to this therapy, administration of nicotinamide (NA) can be bene®cial. This concept is reinforced by the results of a recent meta-analysis of the use of NA in patients with recent-onset Type 1

Clinical trial: evaluation of gastric ac

Clinical trial: evaluation of gastric acid suppression with three doses of immediate-release esomeprazole in the fixed-dose combination of PN 400 (naproxen/esomeprazole magnesium) compared with naproxen 500 mg and enteric-coated esomeprazole 20 mg: a randomized, open-label, Phase I study in healthy volunteers

✍ P. Miner Jr; J. Plachetka; E. Orlemans; J. G. Fort; M. Sostek 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB

Standard graft-versus-host disease proph

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

✍ Jürgen Finke; Wolfgang A Bethge; Claudia Schmoor; Hellmut D Ottinger; Matthias S 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 237 KB